相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Current Melanoma Treatments: Where Do We Stand?
Alvaro Moreira et al.
CANCERS (2021)
Development of an Immune-Related Gene Signature for Prognosis in Melanoma
Jia-An Zhang et al.
FRONTIERS IN ONCOLOGY (2021)
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition
Kevin Litchfield et al.
CELL (2021)
Intratumoral heterogeneity in cancer progression and response to immunotherapy
Ilio Vitale et al.
NATURE MEDICINE (2021)
CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment
Xuezhi Zhou et al.
FRONTIERS IN ONCOLOGY (2021)
The Next Decade of Immune Checkpoint Therapy
Padmanee Sharma et al.
CANCER DISCOVERY (2021)
A Four-Gene-Based Prognostic Model Predicts Overall Survival in Patients With Cutaneous Melanoma
Xiaoxia Tong et al.
FRONTIERS IN ONCOLOGY (2021)
Circadian Rhythm of NER and ATR Pathways
Tae-Hong Kang
BIOMOLECULES (2021)
cutpointr: Improved Estimation and Validation of Optimal Cutpoints in R
Christian Thiele et al.
JOURNAL OF STATISTICAL SOFTWARE (2021)
Mechanisms of Cancer Resistance to Immunotherapy
Rilan Bai et al.
FRONTIERS IN ONCOLOGY (2020)
Impact of high tumor mutational burden in solid tumors and challenges for biomarker application
Mairead G. McNamara et al.
CANCER TREATMENT REVIEWS (2020)
A decade of immune-checkpoint inhibitors in cancer therapy
Caroline Robert
NATURE COMMUNICATIONS (2020)
Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy
Robert M. Samstein et al.
NATURE CANCER (2020)
Prognostic Implications of Novel Ten-Gene Signature in Uveal Melanoma
Huan Luo et al.
FRONTIERS IN ONCOLOGY (2020)
Genomic correlates of response to immune checkpoint blockade
Tanya E. Keenan et al.
NATURE MEDICINE (2019)
Base excision repair regulates PD-L1 expression in cancer cells
Tiara Bunga Mayang Permata et al.
ONCOGENE (2019)
Observed Survival Interval: A Supplement to TCGA Pan-Cancer Clinical Data Resource
Jie Xiong et al.
CANCERS (2019)
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Tumor mutational and indel burden: a systematic pan-cancer evaluation as prognostic biomarkers
Hao-Xiang Wu et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Cluster analysis on high dimensional RNA-seq data with applications to cancer research - An evaluation study
Linda Vidman et al.
PLOS ONE (2019)
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J. Havel et al.
NATURE REVIEWS CANCER (2019)
Response to Pembrolizumab in a Patient With Xeroderma Pigmentosum and Advanced Squamous Cell Carcinoma
Angela Steineck et al.
JCO PRECISION ONCOLOGY (2019)
Dramatic response to nivolumab in xeroderma pigmentosum skin tumor
Fanny Chambon et al.
PEDIATRIC BLOOD & CANCER (2018)
Efficacy of anti-programmed cell death-1 immunotherapy for skin carcinomas and melanoma metastases in a patient with xeroderma pigmentosum
G. Salomon et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
Katherine A. Hoadley et al.
CELL (2018)
DNA Repair Deficiency and Immunotherapy Response
Kent W. Mouw et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers
Min Yuen Teo et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)
Patrick Danaher et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection
Jonathan A. Trujillo et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Development of PARP and Immune-Checkpoint Inhibitor Combinations
Ross A. Stewart et al.
CANCER RESEARCH (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
DNA repair defects and implications for immunotherapy
Katherine M. Bever et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer
Eileen E. Parkes et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer
Eileen E. Parkes et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Regression of melanoma metastases and multiple non-melanoma skin cancers in xeroderma pigmentosum by the PD1-antibody pembrolizumab
Axel Hauschild et al.
EUROPEAN JOURNAL OF CANCER (2017)
Rapid response of metastatic cutaneous squamous cell carcinoma to pembrolizumab in a patient with xeroderma pigmentosum: Case report and review of the literature
Teresa Deinlein et al.
EUROPEAN JOURNAL OF CANCER (2017)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth
Giovanni Germano et al.
NATURE (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells
Hiro Sato et al.
NATURE COMMUNICATIONS (2017)
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Angel Garcia-Diaz et al.
CELL REPORTS (2017)
Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy
Sacha Gnjatic et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Nadeem Riaz et al.
CELL (2017)
Complex heatmaps reveal patterns and correlations in multidimensional genomic data
Zuguang Gu et al.
BIOINFORMATICS (2016)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Willy Hugo et al.
CELL (2016)
Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts
Sarah A. Weiss et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Density of immunogenic antigens does not explain the presence or absence of the T-cell-inflamed tumor microenvironment in melanoma
Stefani Spranger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
DNA repair, genome stability and cancer: a historical perspective
Penny A. Jeggo et al.
NATURE REVIEWS CANCER (2016)
Genomic Classification of Cutaneous Melanoma
Rehan Akbani et al.
CELL (2015)
MYC Disrupts the Circadian Clock and Metabolism in Cancer Cells
Brian J. Altman et al.
CELL METABOLISM (2015)
Role of DNA repair in host immune response and inflammation
Fabricia Lima Fontes et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Microhomology-Mediated End Joining: A Back-up Survival Mechanism or Dedicated Pathway?
Agnel Sfeir et al.
TRENDS IN BIOCHEMICAL SCIENCES (2015)
Adaptive Immune Resistance: How Cancer Protects from Immune Attack
Antoni Ribas
CANCER DISCOVERY (2015)
Understanding nucleotide excision repair and its roles in cancer and ageing
Jurgen A. Marteijn et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Nucleotide Excision Repair in Eukaryotes
Orlando D. Schaerer
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Comparison of ERCC1/XPF genetic variation, mRNA and protein levels in women with advanced stage ovarian cancer treated with intraperitoneal platinum
Julie A. DeLoia et al.
GYNECOLOGIC ONCOLOGY (2012)
DNA repair endonuclease ERCC1-XPF as a novel therapeutic target to overcome chemoresistance in cancer therapy
Ewan M. McNeil et al.
NUCLEIC ACIDS RESEARCH (2012)
Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair
Porcia T. Bradford et al.
JOURNAL OF MEDICAL GENETICS (2011)
The XPA-binding domain of ERCC1 Is Required for Nucleotide Excision Repair but Not Other DNA Repair Pathways
Barbara Orelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Structure and mechanism of human DNA polymerase η
Christian Biertuempfel et al.
NATURE (2010)
Prognostic versus predictive value of biomarkers in oncology
C. N. A. M. Oldenhuis et al.
EUROPEAN JOURNAL OF CANCER (2008)
Structural basis for the recruitment of ERCC1-XPF to nucleotide excision repair complexes by XPA
Oleg V. Tsodikov et al.
EMBO JOURNAL (2007)
Differential ultraviolet-B-induced immunomodulation in XPA, XPC, and CSB DNA repair-deficient mice
A Boonstra et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
分享论文
